Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Minerva Anestesiologica
|
March 1, 1990
[Propofol-ketamine vs propofol-fentanyl in short gynecologic surgery]
A Sicignano, V Bellato, F Cancellieri, et al.
Minerva Anestesiologica
|
October 1, 1990
[Complement anaphylotoxins and elastases in sepsis]
S Vesconi, C Foroni, A Sicignano, et al.
Minerva Anestesiologica
|
October 1, 1991
[Complement activation and role of anaphylotoxin in septic syndrome]
V Bellato, C Foroni, A Sicignano, et al.
British Journal of Cancer
|
April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G Allevi, C Strina, D Andreis, et al.
British Journal of Cancer
|
December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
L Bazzola, C Foroni, D Andreis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Minerva Anestesiologica
|
March 1, 1990
[Propofol-ketamine vs propofol-fentanyl in short gynecologic surgery]
A Sicignano, V Bellato, F Cancellieri, et al.
Minerva Anestesiologica
|
October 1, 1990
[Complement anaphylotoxins and elastases in sepsis]
S Vesconi, C Foroni, A Sicignano, et al.
Minerva Anestesiologica
|
October 1, 1991
[Complement activation and role of anaphylotoxin in septic syndrome]
V Bellato, C Foroni, A Sicignano, et al.
British Journal of Cancer
|
April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G Allevi, C Strina, D Andreis, et al.
British Journal of Cancer
|
December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
L Bazzola, C Foroni, D Andreis, et al.
Page
of 2